Joan H Schiller

Joan H Schiller

UNVERIFIED PROFILE

Are you Joan H Schiller?   Register this Author

Register author
Joan H Schiller

Joan H Schiller

Publications by authors named "Joan H Schiller"

Are you Joan H Schiller?   Register this Author

100Publications

2671Reads

28Profile Views

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.

Cancer Inform 2019 5;18:1176935119837547. Epub 2019 Apr 5.

Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1176935119837547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452590PMC
April 2019

A New Standard of Care for Advanced Lung Cancer.

Authors:
Joan H Schiller

N Engl J Med 2018 05;378(22):2135-2137

From the Inova Schar Cancer Institute, Fairfax, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1804364DOI Listing
May 2018

Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients.

J Oncol Pract 2017 12 5;13(12):780-783. Epub 2017 Oct 5.

Johns Hopkins, Baltimore, MD; Indiana University, Bloomington, IN; UT Southwestern Medical School, Dallas, TX; Virginia Commonwealth University Massey Cancer Center, Richmond; Inova Schar Cancer Institute, Falls Church; ASCO, Alexandria, VA; Einstein Medical Center, Philadelphia, PA; Juravinski Cancer Centre, Hamilton; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Lombardi Cancer Center, Washington, DC; Lahey Hospital & Medical Center, Burlington, MA; William Beaumont Hospital, Royal Oak; University of Michigan, Ann Arbor, MI; Memorial Sloan Kettering Cancer Center, New York, NY; Circle of Hope for Cancer Research, St Cloud, FL; and Helen F. Graham Cancer Center, Newark, DE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.027367DOI Listing
December 2017

Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.

J Thorac Oncol 2017 10 9;12(10):1489-1495. Epub 2017 Aug 9.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.07.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610621PMC
October 2017

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2017 Oct 14;35(30):3484-3515. Epub 2017 Aug 14.

Nasser Hanna, Indiana University Simon Cancer Center, Indianapolis, IN; David Johnson, University of Texas Southwestern Medical Center, Dallas, TX; Sarah Temin, American Society of Clinical Oncology, Alexandria; Sherman Baker Jr, Virginia Commonwealth University Health System Massey Cancer Center, Richmond; Joan H. Schiller, Inova Schar Cancer Institute, Fairfax, VA; Julie Brahmer and Thomas J. Smith, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Peter M. Ellis, Juravinski Cancer Centre, Hamilton; Natasha B. Leighl, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Giuseppe Giaccone, Georgetown University, Washington, DC; Paul J. Hesketh, Lahey Hospital and Medical Center, Burlington, MA; Ishmael Jaiyesimi, William Beaumont Hospital, Royal Oak; Bryan J. Schneider, University of Michigan Health System, Ann Arbor, MI; Gregory J. Riely, Memorial Sloan-Kettering Cancer Center, New York, NY; Joan Tashbar, Circle of Hope for Cancer Research, Orlando, FL; William A. Biermann, Einstein Medical Center Montgomery, East Norriton, PA; and Gregory Masters, Helen F. Graham Cancer Center and Research Institute, Newark, DE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.6065DOI Listing
October 2017

Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.

J Clin Oncol 2017 Sep 11;35(25):2885-2892. Epub 2017 May 11.

Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.4758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578390PMC
September 2017

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

J Clin Oncol 2017 Jul 10;35(19):2184-2192. Epub 2017 May 10.

Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Xiaofei Wang and Lydia Hodgson, Alliance Statistical and Data Center, Duke University; Thomas E. Stinchcombe, Duke University School of Medicine, Durham, NC; Richard T. Cheney, Roswell Park Cancer Institute, Buffalo; Ajeet Gajra, State University of New York Upstate Medical University, Syracuse, NY; Maria Q. Baggstrom, Washington University School of Medicine, St Louis, MO; Sachdev P. Thomas, Illinois Cancer Care, Peoria; Paula N. Friedman and Everett E. Vokes, University of Chicago; Olwen M. Hahn, Alliance Protocol Office, University of Chicago, Chicago, IL; Erin Bertino, The Ohio State University Medical Center, Columbus, OH; Karen L. Reckamp, City of Hope Comprehensive Cancer Center, Duarte, CA; Julian Molina, Mayo Clinic, Rochester; Jon Ritter, University of Minnesota, Minneapolis, MN; Joan H. Schiller, University of Texas Southwestern Medical Center, Dallas, TX; Kisha Mitchell-Richards, Yale University, New Haven, CT; and Ginger Milne, Vanderbilt University, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493050PMC
July 2017

Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam Systems.

J Oncol Pract 2016 11 30;12(11):1020-1028. Epub 2016 Sep 30.

University of Texas Southwestern Medical Center and Texas Oncology, Dallas, TX; and Purdue University, West Lafayette, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455413PMC
November 2016

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials.

Am J Clin Oncol 2016 10;39(5):441-7

*Abramson Cancer Center, University of Pennsylvania, Philadelphia †University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA ‡Feinberg School of Medicine, Northwestern University, Chicago, IL §Genentech Inc., South San Francisco, CA ∥Harold C. Simmons Cancer Center, University of Texas Southwestern, Dallas, TX ¶Winship Cancer Institute of Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016219PMC
October 2016

Attitudes and Stereotypes in Lung Cancer versus Breast Cancer.

PLoS One 2015 23;10(12):e0145715. Epub 2015 Dec 23.

Division of Hematology and Oncology Division, University of Texas Southwestern, Dallas, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145715PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689531PMC
July 2016

Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer.

Lung Cancer 2015 Dec 9;90(3):534-41. Epub 2015 Oct 9.

Department of Internal Medicine (Division of Hematology-Oncology), USA; Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.10.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125089PMC
December 2015

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2015 Oct 31;33(30):3488-515. Epub 2015 Aug 31.

Gregory A. Masters, Helen F. Graham Cancer Center, Newark, DE; Sarah Temin, American Society of Clinical Oncology, Alexandria; Sherman Baker Jr, Virginia Commonwealth University; David Trent, Virginia Cancer Center, Richmond, VA; Christopher G. Azzoli, Massachusetts General Hospital Cancer Center, Boston, MA; Giuseppe Giaccone, Lombardi Cancer Center, Georgetown University, Washington, DC; Julie R. Brahmer and Thomas J. Smith, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Peter M. Ellis, Juravinski Cancer Centre, Hamilton, Ontario, Canada; Ajeet Gajra, Upstate Medical University, Syracuse, NY; Nancy Rackear, Uniting Against Lung Cancer, Fort Lauderdale, FL; Joan H. Schiller, University of Texas Southwestern; David H. Johnson, University of Texas Southwestern Medical Center at Dallas, Dallas; and John R. Strawn, patient representative, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.1342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019421PMC
October 2015

The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases.

Clin Cancer Res 2015 Oct;21(20):4561-8

University of California San Diego Moores Cancer Center, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3246DOI Listing
October 2015

Anti-EGFR monoclonal antibodies in lung cancer treatment.

Authors:
Joan H Schiller

Lancet Oncol 2015 Jul 1;16(7):738-9. Epub 2015 Jun 1.

Division of Hematology and Oncology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00020-0DOI Listing
July 2015

Reply to A. Braillon.

J Clin Oncol 2014 Nov 15;32(31):3575. Epub 2014 Sep 15.

University of Colorado Cancer Center, Aurora, CO

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.2545DOI Listing
November 2014

Recent clinical advances in lung cancer management.

J Clin Oncol 2014 Apr 24;32(10):973-82. Epub 2014 Feb 24.

University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1228DOI Listing
April 2014

Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.

J Thorac Oncol 2014 Apr;9(4):456-63

*Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX; †Department of Pathology, UT Southwestern Medical Center, Dallas, TX; ‡Cancer Genetics, Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX; §Department of Clinical Science and McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX; ‖Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; ¶Department of Thoracic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan; #Department of Radiology, UT Southwestern Medical Center, Dallas, TX; **Department of Clinical Science and Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX; ††Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, Dallas, TX; and ‡‡Department of Medicine and Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509739PMC
April 2014

Stigma among patients with lung cancer: a patient-reported measurement model.

Psychooncology 2014 Jan 3;23(1):81-92. Epub 2013 Oct 3.

Harold C. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936675PMC
January 2014

Clinician perceptions of care difficulty, quality of life, and symptom reports for lung cancer patients: an analysis from the Symptom Outcomes and Practice patterns (SOAPP) study.

J Thorac Oncol 2013 Dec;8(12):1474-83

*Harold C. Simmons Cancer Center, Departments of Psychiatry and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas; †Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts; ‡Harold C. Simmons Cancer Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; §Department of Medical Oncology, Vanderbilt University, Nashville, Tennessee; ‖Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois; ¶VA New Jersey Health Care System, East Orange, New Jersey, Rutgers - New Jersey Medical School, Newark, New Jersey; and #Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153012
Publisher Site
http://dx.doi.org/10.1097/01.JTO.0000437501.83763.5dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936653PMC
December 2013

Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: a randomized phase 2 PrECOG study (PrE0501).

J Thorac Oncol 2013 Aug;8(8):1075-83

Department of Medical Oncology, Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182937317DOI Listing
August 2013

Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594.

Lung Cancer 2013 Jul 21;81(1):47-52. Epub 2013 Apr 21.

Hematology-Oncology Section, University of Wisconsin, Wisconsin Institutes for Medical Research, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264629PMC
July 2013

Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea.

J Clin Oncol 2013 Mar 11;31(8):1009-20. Epub 2013 Feb 11.

Division of Hematology-Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390-8852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.7459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589699PMC
March 2013

Non-small-cell lung cancer: then and now.

J Clin Oncol 2013 Mar 11;31(8):981-3. Epub 2013 Feb 11.

Division of Hematology-Oncology, University of Texas Southwestern, Dallas, TX 75390-8852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.5772DOI Listing
March 2013

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors.

Cancer Treat Rev 2013 Feb 19;39(1):27-43. Epub 2012 Apr 19.

University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213-1862, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.03.007DOI Listing
February 2013

The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer.

Oncol Rep 2011 Jun 6;25(6):1765-72. Epub 2011 Apr 6.

School of Pharmacy, University of Wisconsin Paul P Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53792-5669, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2011.1249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211091PMC
June 2011

Diastolic blood pressure as a biomarker of axitinib efficacy in solid tumors.

Clin Cancer Res 2011 Jun 29;17(11):3841-9. Epub 2011 Apr 29.

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2806DOI Listing
June 2011

Putting lung cancer clinical trials into perspective.

Oncology (Williston Park) 2011 Jan;25(1):78, 80

Internal Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
January 2011

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study.

Cancer Chemother Pharmacol 2010 Sep 31;66(4):669-80. Epub 2009 Dec 31.

Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1209-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904454PMC
September 2010

A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.

Invest New Drugs 2010 Feb 24;28(1):91-7. Epub 2009 Feb 24.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, K6/568 CSC, #5669, 600 Highland Avenue, Madison, WI, 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9230-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045859PMC
February 2010

Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.

J Clin Oncol 2010 Feb 19;28(6):949-54. Epub 2010 Jan 19.

Department of Biostatistics and Computational Biology, CLSB 11007, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.25.4482
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.25.4482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834434PMC
February 2010

Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.

Lung Cancer 2009 Apr 12;64(1):51-9. Epub 2008 Aug 12.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164240PMC
April 2009

DNA methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer.

Nutr Rev 2008 Aug;66 Suppl 1:S24-6

The Lung Cancer Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87108, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1753-4887.2008.00061.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683838PMC
August 2008

Noninvasive monitoring of tumors.

Authors:
Joan H Schiller

N Engl J Med 2008 Jul 2;359(4):418-20. Epub 2008 Jul 2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe0804521DOI Listing
July 2008

Addressing the current challenges of non-small-cell lung cancer clinical trial accrual.

Clin Lung Cancer 2008 Jul;9(4):222-6

Department of Radiation Oncology, The Emory Clinic, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.033DOI Listing
July 2008

Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer.

Clin Lung Cancer 2008 May;9(3):171-8

University of Wisconsin Paul P Carbone Comprehensive Cancer Center, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.026DOI Listing
May 2008

Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).

Authors:
Joan H Schiller

Cancer Invest 2008 Feb;26(1):81-95

University of Texas-Southwestern, Dallas, Texas 75390-8852, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/0735790070151184
Publisher Site
http://dx.doi.org/10.1080/07357900701511847DOI Listing
February 2008

Lung cancer in never smokers--a different disease.

Nat Rev Cancer 2007 Oct;7(10):778-90

Division of Haematology and Oncology and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2190DOI Listing
October 2007

New molecularly targeted therapies for lung cancer.

J Clin Invest 2007 Oct;117(10):2740-50

Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI31809DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994616PMC
October 2007

Differences in primary care clinicians' approach to non-small cell lung cancer patients compared with breast cancer.

J Thorac Oncol 2007 Aug;2(8):722-8

University of Wisconsin School of Medicine and Public Health, Department of Medicine, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3180cc2599DOI Listing
August 2007

Angiogenesis inhibitors in the treatment of lung cancer.

Crit Rev Oncol Hematol 2007 May 15;62(2):93-104. Epub 2007 Feb 15.

Division of Hematology and Oncology, University of Texas Southwestern, Dallas 75390-8852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2007.01.002DOI Listing
May 2007

EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.

J Thorac Oncol 2006 Jun;1(5):406-12

University of California, San Francisco, San Francisco, California 94115, USA.

View Article

Download full-text PDF

Source
June 2006

Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.

J Thorac Oncol 2006 Jun;1(5):441-6

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA 94305-5826, USA.

View Article

Download full-text PDF

Source
June 2006

Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.

Cancer 2006 May;106(10):2208-17

Department of Medicine, Division of Medical Oncology, Stanford Cancer Center, Stanford University, Stanford, California 94305-5826, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21869
Publisher Site
http://dx.doi.org/10.1002/cncr.21869DOI Listing
May 2006

Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.

J Thorac Oncol 2006 Mar;1(3):218-25

Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
March 2006

Phase I study of docetaxel and topotecan in patients with advanced malignancies.

J Oncol Pharm Pract 2005 Dec;11(4):131-8

Department of Medicine, Medical Oncology Section, University of Wisconsin Comprehensive Cancer Center, Madison, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1191/1078155205jp161oaDOI Listing
December 2005

Epidermal growth factor receptor as a therapeutic target in lung cancer.

Authors:
Joan H Schiller

Semin Respir Crit Care Med 2004 ;25 Suppl 1:11-6

Comprehensive Cancer Center, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2004-829640DOI Listing
October 2005

Targeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors: novel agents with potential in lung cancer.

Clin Lung Cancer 2005 Sep;7 Suppl 1:S31-8

Oncology Division, Stanford University School of Medicine, CA, USA.

View Article

Download full-text PDF

Source
September 2005

Study design issues and early stage non-small cell lung cancer.

Authors:
Joan H Schiller

Clin Cancer Res 2005 Jul;11(13 Pt 2):5030s-5032s

University of Wisconsin Comprehensive Cancer Center, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-05-9003DOI Listing
July 2005

Using liquid crystals to report membrane proteins captured by affinity microcontact printing from cell lysates and membrane extracts.

J Am Chem Soc 2005 Jun;127(25):8912-3

Department of Chemical and Biological Engineering,University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ja051079gDOI Listing
June 2005

Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab.

Oncologist 2005 Apr;10(4):282-91

University of Wisconsin Comprehensive Cancer Center, 600 Highland Avenue, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.10-4-282DOI Listing
April 2005